AI assistant
NETCALL PLC — Director's Dealing 2026
Mar 17, 2026
7808_dirs_2026-03-17_2aa6146f-9626-407a-8ea7-aa6fc236d56f.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 0345X
Netcall PLC
17 March 2026
17 March 2026
NETCALL PLC
("Netcall", the "Company" or the "Group")
Director/PDMR Dealing
Netcall plc (AIM: NET), an enterprise software company that unites automation and customer engagement in one AI-powered platform, announces the purchase of 5,000 ordinary shares of 5 pence each ("Ordinary Shares") by Nigel Halkes, Non-Executive Director.
Following the purchase of 5,000 Ordinary Shares, Mr Halkes' shareholding is 10,000 Ordinary Shares.
For further enquiries, please contact:
| Netcall plc | Tel. +44 (0) 330 333 6100 |
| James Ormondroyd, CEO Richard Hughes, CFO Henrik Bang, Non-Executive Chair |
|
| Canaccord Genuity Limited (Nominated Adviser and Joint Broker) | Tel. +44 (0) 20 7523 8000 |
| Simon Bridges / Harry Gooden / Andrew Potts | |
| Singer Capital Markets (Joint Broker) | Tel. +44 (0) 20 7496 3000 |
| Charles Leigh-Pemberton / James Moat / Anastassiya Eley | |
| Alma Strategic Communications | Tel. +44 (0) 20 3405 0205 |
| Caroline Forde / Hilary Buchanan / Emma Thompson |
About Netcall
Netcall (AIM: NET) is a UK-based enterprise software company that unites automation and customer engagement in one AI-powered platform. Its Liberty platform makes work easier by digitising processes and simplifying customer interactions in a single, easy-to-use solution that reduces complexity. Today, around 700 organisations across healthcare, government and financial services depend on Netcall for business‑critical workflows, including two‑thirds of NHS Acute Health Trusts, one half of UK local authorities and major enterprises such as Legal & General, Baloise and Santander. For further information, please go to www.netcall.com.
1.
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Nigel Halkes
2.
Reason for the Notification
a)
Position/status
Non-Executive Director
b)
Initial notification/Amendment
Initial Notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
b)
LEI
213800GZHEAA98QBJY98
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the Financial instrument, type of instrument
Ordinary Shares
Identification code
GB0000060532
b)
Nature of the transaction
Purchase of ordinary shares
c)
Price(s) and volume(s)
| Price(s) | Volume(s) | |
| 97.45 p | 5,000 |
d)
Aggregated information:
Aggregated volume
Price
5,000 Ordinary Shares purchased at a price of 97.45 pence per Ordinary Share
e)
Date of the transaction
17 March 2026
f)
Place of the transaction
London Stock Exchange (XLON)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHFZGMFNNRGVZM